Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11137300rdf:typepubmed:Citationlld:pubmed
pubmed-article:11137300lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11137300lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:11137300lifeskim:mentionsumls-concept:C0017428lld:lifeskim
pubmed-article:11137300lifeskim:mentionsumls-concept:C0041485lld:lifeskim
pubmed-article:11137300lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:11137300lifeskim:mentionsumls-concept:C1334805lld:lifeskim
pubmed-article:11137300pubmed:issue1-2lld:pubmed
pubmed-article:11137300pubmed:dateCreated2001-1-23lld:pubmed
pubmed-article:11137300pubmed:abstractTextPTP-1B is a ubiquitously expressed intracellular protein tyrosine phosphatase (PTP) that has been implicated in the negative regulation of insulin signaling. Mice deficient in PTP-1B were found to have an enhanced insulin sensitivity and a resistance to diet-induced obesity. Interestingly, the human PTP-1B gene maps to chromosome 20q13.1 in a region that has been associated with diabetes and obesity. Although there has been a partial characterization of the 3' end of the human PTP-1B gene, the complete gene organization has not been described. In order to further characterize the PTP-1B gene, we have cloned and determined the genomic organization for both the human and mouse PTP-1B genes including the promoter. The human gene spans >74 kb and features a large first intron of >54 kb; the mouse gene likewise contains a large first intron, although the exact size has not been determined. The organization of the human and mouse PTP-1B genes is identical except for an additional exon at the 3' end of the human that is absent in the mouse. The mouse PTP-1B gene maps to the distal arm of mouse chromosome 2 in the region H2-H3. This region is associated with a mouse obesity quantitative trait locus (QTL) and is syntenic with human chromosome 20. The promoter region of both the human and mouse genes contain no TATA box but multiple GC-rich sequences that contain a number of consensus SP-1 binding sites. The basal activity of the human PTP-1B promoter was characterized in Hep G2 cells using up to 8 kb of 5' flanking sequence. A 432 bp promoter construct immediately upstream of the ATG was able to confer maximal promoter activity. Within this sequence, there are at least three GC-rich sequences and one CCAAT box, and deletion of any of these elements results in decreased promoter activity. In addition, the promoter in a number of mouse strains contains, 3.5 kb upstream of the start codon, an insertion of an intracisternal a particle (IAP) element that possibly could alter the expression of PTP-1B mRNA in these strains.lld:pubmed
pubmed-article:11137300pubmed:languageenglld:pubmed
pubmed-article:11137300pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11137300pubmed:citationSubsetIMlld:pubmed
pubmed-article:11137300pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11137300pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11137300pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11137300pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11137300pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11137300pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11137300pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11137300pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11137300pubmed:statusMEDLINElld:pubmed
pubmed-article:11137300pubmed:monthDeclld:pubmed
pubmed-article:11137300pubmed:issn0378-1119lld:pubmed
pubmed-article:11137300pubmed:authorpubmed-author:CollinsSSlld:pubmed
pubmed-article:11137300pubmed:authorpubmed-author:KennedyB PBPlld:pubmed
pubmed-article:11137300pubmed:authorpubmed-author:BoieYYlld:pubmed
pubmed-article:11137300pubmed:authorpubmed-author:ForsellP APAlld:pubmed
pubmed-article:11137300pubmed:authorpubmed-author:MontalibetJJlld:pubmed
pubmed-article:11137300pubmed:issnTypePrintlld:pubmed
pubmed-article:11137300pubmed:day30lld:pubmed
pubmed-article:11137300pubmed:volume260lld:pubmed
pubmed-article:11137300pubmed:ownerNLMlld:pubmed
pubmed-article:11137300pubmed:authorsCompleteYlld:pubmed
pubmed-article:11137300pubmed:pagination145-53lld:pubmed
pubmed-article:11137300pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:meshHeadingpubmed-meshheading:11137300...lld:pubmed
pubmed-article:11137300pubmed:year2000lld:pubmed
pubmed-article:11137300pubmed:articleTitleGenomic characterization of the human and mouse protein tyrosine phosphatase-1B genes.lld:pubmed
pubmed-article:11137300pubmed:affiliationDepartment of Biochemistry and Molecular Biology, Merck Frosst Center for Therapeutic Research, Kirkland, Quebec H9H 3L1, Canada.lld:pubmed
pubmed-article:11137300pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11137300pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:19246entrezgene:pubmedpubmed-article:11137300lld:entrezgene
entrez-gene:111993entrezgene:pubmedpubmed-article:11137300lld:entrezgene
entrez-gene:114621entrezgene:pubmedpubmed-article:11137300lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11137300lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11137300lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11137300lld:pubmed